FDA/CDC
FDA/CDC
FDA clears once-weekly transdermal patch for Alzheimer’s
Adlarity is the first and only once-weekly patch to continuously deliver consistent doses of the acetylcholinesterase inhibitor through the skin...
Latest News
FDA approves first PARP inhibitor for early
BRCA+ breast cancer
FDA/CDC
FDA approves neoadjuvant nivolumab/chemo for early-stage NSCLC
Nivolumab is the first immune checkpoint inhibitor to be approved for resectable NSCLC.
FDA/CDC
FDA approves first drug for myelofibrosis with thrombocytopenia
Treatment option is the first for patients who have myelofibrosis with low platelet counts.
Latest News
FDA approves new CAR T-cell treatment for multiple myeloma
Study results show that this treatment for refractory/relapsed multiple myeloma can provide deep, durable responses and long treatment-free...
Latest News
Why pregnant people were left behind while vaccines moved at ‘warp speed’ to help the masses
A growing number of women’s health researchers and advocates say that excluding pregnant people – and the months-long delay in recommending that...
FDA/CDC
FDA okays empagliflozin for HF regardless of ejection fraction
The expanded indication for the SGLT2 inhibitor empagliflozin (Jardiance) now includes heart failure with mid-range or preserved left ventricular...
FDA/CDC
FDA approves first drug for rare inherited anemia
First-ever drug for hemolytic anemia has been approved by the Food and Drug Administration.
FDA/CDC
AAP approves CDC’s child/adolescent vax schedule for 2022
A new vaccine has been added to the schedule.
FDA/CDC
ACIP issues adult vaccination schedule 2022
“Providers should administer all due and overdue vaccines according to the routine immunization schedule during the same visit.”